Micro-Nano Technology for Genomics and Proteomics BioMEMs - Ozkan
.pdfPEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
233 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
8 anti-sIL-6R mabs |
partial peptide scans of the IL-6 |
SPOT |
[192] |
|
receptor extracellular domain |
|
|
anti-dynorphin B mab D32.39 and goat |
deletions and truncations of |
LDPS |
[213] |
anti-mouse IgG-FITC conjugate or |
FLRRQFKVVT (1024 peptides) |
|
|
mab D32.39-FITC conjugate |
|
|
|
anti-transforming growth factor α |
combinatorial clustered hexapeptide |
SPOT |
[271] |
(TGFα) mab Tab2 |
library and deconvolution libraries |
|
|
6 mabs against phosphoprotein |
peptide scans of the P-proteins of |
SPOT |
[348] |
(P-protein) of morbillivirus strains |
morbillivirus strains PDV and CDV |
|
|
PDV and CDV |
|
|
|
anti-protein-S of transmissible |
4450 randomly generated 12-mer |
MPC |
[516] |
gastroenteritis virus (TGEV) mabs |
peptides; all 8000 tripeptides based |
|
|
6A.A6 and 57.9; anti-EGF-like |
on the genetically encoded amino |
|
|
domain of surface protein pfs25 of |
acids |
|
|
Plasmodium falciparum mab 32F81 |
|
|
|
anti-gp41 (HIV-1) mab 3D6 |
complete L- and D amino acid |
SPOT |
[528] |
|
substitutional analyses of the linear |
|
|
|
epitope |
|
|
6 anti-listeriolysin (Listeria |
peptide scans of listriolysin |
SPOT |
[98] |
monocytogenes) mabs |
|
|
|
anti-porcine tubulin-tyrosine ligase |
peptide scan of porcine |
SPOT |
[158] |
(TTL) mab 1D3 |
tubulin-tyrosine ligase (TTL), |
|
|
|
substitutional and truncation |
|
|
|
analysis of a selected peptide, |
|
|
|
combinatorial library (XXB1B2XX) |
|
|
anti-porcine tubulin-tyrosine ligase |
substitutional and truncation analysis |
SPOT |
[159] |
(TTL) mab 1D3 |
of a TTL-derived peptide; |
|
|
|
combinatorial library (XXB1B2XX) |
|
|
|
and deconvolution libraries |
|
|
streptavidin-alkaline phosphatase |
combinatorial library (XXB1B2XX) |
|
|
|
and deconvolution libraries |
|
|
cAMP-dependent protein kinase |
combinatorial library (XXB1B2XX) |
|
|
|
and deconvolution libraries |
|
|
5 polyclonal anti-U1 small nuclear |
peptide scans of U1 snRNP-C |
SPOT |
[193] |
ribonucleoprotein complex (U1 |
|
|
|
snRNP-C) antibodies (rabbit); 5 sera |
|
|
|
from patients with mixed connective |
|
|
|
tissue disease (MCTD) or systemic |
|
|
|
lupus erythematosus (SLE) |
|
|
|
rabbit serum against a peptide derived |
partial peptide scan of the β-antigen of |
SPOT |
[239] |
from the β-antigen of the c protein |
the c protein complex of group B |
|
|
complex of group B streptococci |
streptococci and truncation analysis |
|
|
|
of a selected peptide |
|
|
12 sera from patients with |
peptide scans of intestinal alkaline |
SPOT |
[264] |
autoantibodies against intestinal |
phosphatase (IAP) |
|
|
alkaline phosphatase (IAP) |
|
|
|
anti-gp41 (HIV-1) mab 2F5 |
complete L-amino acid substitutional |
SPOT |
[436] |
|
analysis of the epitope peptide |
|
|
(cont.)
234 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
anti-transforming growth factor α |
substitutional analyses; combinatorial |
SPOT |
[494] |
(TGFα) mab Tab2; anti-p24 |
library of the type |
|
|
(HIV-1) mab CB4-1 |
XXXXB1B2B3XXXX; positional |
|
|
|
scanning combinatorial library |
|
|
lead(II); calcium(II); iron(III); |
combinatorial libraries of the type |
|
|
silver(I); nickel(II); technetium-99m |
XB1XB2XX; deconvolution |
|
|
|
libraries; positional scanning library |
|
|
2 anti-presenilin 1 (PS1) polyclonal |
partial peptide scans of presenilin 1 |
SPOT |
[542] |
rabbit antisera |
|
|
|
human antiserum against pertussis |
peptide scan of pertussis toxin |
SPOT |
[575] |
toxin |
|
|
|
3 anti-FcRIIb2 mabs |
peptide scans of FcRIIb2 |
SPOT |
[586] |
pooled sera from 10 latex-sensitized |
peptide scan of the latex allergy |
SPOT |
[20] |
health care workers; pooled sera |
associated allergen prohevin |
|
|
from 10 patients with spina bifida |
|
|
|
pooled sera from latex-allergic |
peptide scans of prohevein |
SPOT |
[29] |
patients; serum from a single latex |
|
|
|
allergic patient; high IgE control |
|
|
|
sera; pooled anti-latex rabbit sera |
|
|
|
anti-RhopH3 (Plasmodium |
partial peptide scan (aa 816-836) of |
SPOT |
[119] |
falciparum) mouse mabs 84, 85, 87, |
RhopH3 |
|
|
and 91 |
|
|
|
serum from a juvenile rheumatoid |
partial peptide scan of the nucleosomal |
SPOT |
[248] |
arthritis (JRA) patient |
high mobility group protein 2 |
|
|
|
(HMG-2) and a glycine walk of a |
|
|
|
selected peptide |
|
|
anti-p24 (HIV-1) mab CB4-1 |
positional scanning combinatorial L- |
SPOT |
[272] |
|
and D-amino acid libraries, |
|
|
|
deconvolution libraries, |
|
|
|
substitutional analyses |
|
|
2 mabs against the heavy chain of |
peptide scans of two regions of |
SPOT |
[279] |
botulinum type E neurotoxin |
botulinum type E neurotoxin |
|
|
9 sera from patients with |
peptide scan of the C-terminal |
SPOT |
[312] |
Goodpasture’s disease |
noncollagenous domain of the α3 |
|
|
|
chain of type VI collagen |
|
|
anti-profilin mab 2H11 |
peptide scan of bovine profiling I |
SPOT |
[357] |
anti-human thyroglobulin (hTg) mouse |
partial peptide scan of the central part |
SPOT |
[372] |
mabs Tg2 and Tg8 |
of human thyroglobulin (hTg) |
|
|
mAb 3E7 and goat anti-mouse |
endorphin epitope derived peptides up |
LDPS |
[422] |
IgG-FITC conjugate |
to 16-mers (65536 peptides) |
|
|
anti-troponin I mabs |
peptide scans of sceletal troponin I |
SPOT |
[440] |
HIV-1 positive sera |
peptide scans of the gp120 (HIV-1) V3 |
SPOT |
[497] |
|
loop |
|
|
anti-protein-S of transmissible |
4450 randomly generated 12-mer |
MPC |
[517] |
gastroenteritis virus (TGEV) mabs |
peptides; all 8000 tripeptides based |
|
|
6A.A6; anti-FLAG mab M2 |
on the genetically encoded amino |
|
|
|
acids |
|
|
mab 755 against the α-chain of C3 |
peptide of the C-terminal region of the |
SPOT |
[569] |
|
C3 α-chain |
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
235 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
10 antibodies against ras proteins |
peptide scans of the human oncogene |
SPOT |
[579] |
|
products Ha-ras, K-ras, and N-ras; |
|
|
|
truncation analyses and complete |
|
|
|
L-amino acid substitutional analyses |
|
|
|
of selected peptides |
|
|
anti-elongation factor TU (EF-TU) |
peptide scan of EF-TU, truncation and |
SPOT |
[18] |
mab |
substitutional analysis of a selected |
|
|
|
peptide |
|
|
2 anti-centrosome scleroderma |
peptide scans of the immunogenic |
SPOT |
[23] |
autoimmune sera |
regions of the centrosome autoantigen |
|
|
|
PCM-1 |
|
|
anti-lipoprotein lipase (LPL) mab |
peptide scan of LPL and substitutional |
SPOT |
[74] |
(discontinuos epitope possible) |
analyses of selected peptides |
|
|
anti-glucoamylase |
partial peptide scan of glucoamylase |
SPOT |
[123] |
(thermoanaerobacterium |
|
|
|
thermosaccharolyticum) polyclonal |
|
|
|
antibody |
|
|
|
anti-M2 acetylcholine receptor mab |
partial peptide scan of M2 acetylcholine |
SPOT |
[131] |
|
receptor |
|
|
anti-cardiac troponin I monoclonal and |
peptide scans of cardiac troponin I |
SPOT |
[145] |
polyclonal antibodies |
|
|
|
28 anti-cardiac troponin I (cTnI) mabs |
peptide scans of cTnI |
SPOT |
[150] |
IgG fractions from 2 patients with |
partial peptide scan of the C-terminal |
SPOT |
[152] |
erythema multiforme major, |
part of desmoplakin |
|
|
polyclonal serum from a rabbit |
|
|
|
immunized containing the epitope |
|
|
|
YSYSYS |
|
|
|
3 anti-C3aR scFvs |
peptide scans of the second extracellular |
SPOT |
[198] |
|
loop of C3aR |
|
|
anti-alanine dehydrogenase (AlaDH) |
peptide scan of AlaDH |
SPOT |
[224] |
of Mycobacterium tubercolosis mab |
|
|
|
HBT-10 |
|
|
|
anti-transforming growth factor α |
peptide scan of TGFα, substitutional |
SPOT |
[273] |
(TGFα) mab Tab2 |
analysis of a selectd peptide, |
|
|
|
combinatorial library (XXB1B2XX) |
|
|
anti-cholera toxin mab TE33; anti-p24 |
D-amino acid substitutional analyses for |
SPOT |
[274] |
(HIV-1) mab CB4-1 |
the transformation of linear |
|
|
|
wt-epitopes into all-D peptide analogs |
|
|
anti-cardiac troponin I monoclonal and |
peptide scans of cardiac troponin I |
SPOT |
[289] |
polyclonal antibodies |
|
|
|
anti-β2 adrenergic receptor mabs |
peptide scans of the β2 adrenergic |
SPOT |
[297] |
|
receptor and alanine scans of selected |
|
|
|
peptides |
|
|
5 anti-glycoprotein G of HSV-2 (gG-2) |
peptide scans of gG-2 |
SPOT |
[321] |
mabs; 8 anti-gG-2 antibodies |
|
|
|
purified from patients sera |
|
|
|
biotinylated antibodies directed against |
pyrrole peptides (18–39) and (11–24) of |
CPPP |
[328] |
ACTH derived peptides and |
ACTH |
|
|
strepavidin-phycoerythrin conjugate |
|
|
|
(cont.)
236 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
8 anti-gliadin polyclonal rabbit sera; 6 |
peptides identified by phage display |
SPOT |
[389] |
human sera positive for gliadin |
(panning against anti-gliadin rabbit |
|
|
antibodies |
sera) |
|
|
anti-eukaryotic initiation factor 4E |
peptide scans of eIF4E |
SPOT |
[431] |
(eIF4E) mabs |
|
|
|
7 rabbit sera against coxsackievirus A9 |
peptide scans of the capsid proteins |
SPOT |
[435] |
and B3 and against echovirus 11 |
VP1, VP2 and VP3 from |
|
|
|
coxsackievirus A9 |
|
|
interleukin 10 (IL-10), interleukin 10 |
peptide scans of IL-10 and IL-10Rα |
SPOT |
[446] |
receptor a (IL-10Rα), 3 anti-IL-10 |
|
|
|
mabs, 1 anti-IL-10Rα mab |
|
|
|
sera from insulin-dependent diabetes |
peptide scans of glutamic acid |
SPOT |
[468] |
mellitus (IDDM) patients |
decarboxylase 65 (GAD65) and |
|
|
|
alanine scans of selected peptides |
|
|
15 sera from systemic lupus |
peptide scans of the SLE autoantigen |
SPOT |
[469] |
erythematosus (SLE) patients |
SmD1 |
|
|
anti-interferon regulatory factor 1 |
peptide scan of interferon regulatory |
SPOT |
[487] |
(IRF-1) polyclonal antibody |
factor 1 (IRF-1) |
|
|
sera from patients with allergic |
peptide scan of a major allergen (Asp f |
SPOT |
[21] |
bronchopulmonary aspergillosis |
2) of Aspergillus fumigatus; |
|
|
(ABPA) |
truncation scans of selected peptides |
|
|
sera from latex allergic patients and |
peptide scans of the latex protein Hev |
SPOT |
[30] |
sera of rabbits immunized with latex |
b 5 from Hevea brasiliensis |
|
|
proteins |
|
|
|
several sera from patients with primary |
partial peptide scans of the nuclear |
SPOT |
[47] |
biliary cirrhosis containing |
protein sp100 |
|
|
autoantibodies against nuclear |
|
|
|
protein sp100 |
|
|
|
68 murine IgG mabs recognizing linear |
peptide scans, length analyses, |
SPOT |
[113] |
epitopes |
L-substitutional analyses |
|
|
13 sera from multiple sclerosis patients |
peptide scans of TAL-H |
SPOT |
[142] |
positive for human transaldolase |
|
|
|
(TAL-H); 2 anti-TAL-H polyclonal |
|
|
|
rabbit antibodies |
|
|
|
anti-pneumolysin mab PLY-5 |
peptide scan of pneumolysin (PLY) |
SPOT |
[231] |
sera from parvovirus B19 infected |
peptide scans of the VP1 and VP2 |
SPOT |
[250] |
patients |
parvovirus B19 capsid proteins; |
|
|
|
truncation analyses; alanine and |
|
|
|
glycine walks of selected peptides |
|
|
3 mouse mabs and a polyclonal rabbit |
peptide scans of pVIII; truncation |
SPOT |
[259] |
serum against pVIII of filamenteous |
analyses and glycine walks of |
|
|
bacteriophage fd |
selected peptides |
|
|
anti-pre-S1 and pre-S2 (hepatitis B |
peptide scan of the pre-S domain, |
SPOT |
[281] |
virus) mabs 1F6 and MA 18/7 |
substitutional analyses of selected |
|
|
|
peptides |
|
|
anti-RNA polymerase II (Drosophila |
substitutional analysis of the RNA |
SPOT |
[326] |
melanogaster) scFv215 |
polymerase II derived epitope |
|
|
2 anti-interleukin 10 (IL-10) mabs |
peptide scans of IL-10 and |
SPOT |
[449] |
|
substitutional analyses of selected |
|
|
|
peptides |
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
237 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
anti-midsize neurofilament NF-M |
peptide scan of neurofilament NF-M |
SPOT |
[500] |
mab 155 |
|
|
|
anti-colera toxin mab TE33 |
substitutional analyses of mab TE33 |
SPOT |
[529] |
|
binding peptides |
|
|
sera from patients receiving |
peptide scans of streptokinase |
SPOT |
[552] |
streptokinase (SK) therapy |
|
|
|
polyclonal serum against |
peptide scans of the bacteriophage |
SPOT |
[559] |
bacteriophage φ29 connector |
φ29 connector protein (p10) |
|
|
protein |
|
|
|
polyclonal serum against |
peptide scans of the bacteriophage |
SPOT |
[560] |
bacteriophage φ29 connector |
φ29 connector protein (p10) |
|
|
protein |
|
|
|
anti-β-amyloid (Aβ) polyclonal |
peptide scan of apolipoprotein E |
SPOT |
[594] |
antibody |
(apoE) each peptide being flanked |
|
|
|
by randomized positions |
|
|
|
(hybritope scan) |
|
|
sera from latex-sensitized health care |
peptide scan of the latex allergy |
SPOT |
[22] |
workers; sera from patients with |
associated proteins Hev b 1 and |
|
|
spina bifida |
Hev b 3 |
|
|
CD4; anti-gp17 polyclonal antibody |
peptide scan of gp17; alanine walks |
SPOT |
[28] |
|
of selected peptides |
|
|
sera from patients with |
partial peptide scan of the |
SPOT |
[48] |
polymyositis-scleroderma overlap |
polymyositis-scleroderma overlap |
|
|
syndrome |
syndrome antigen PM/Scl-100; |
|
|
|
length analysis, glycine-walk and |
|
|
|
complete substitutional analysis of |
|
|
|
a selected positive peptide from the |
|
|
|
peptide scan |
|
|
mab 2E11 against a peptide 38 from |
truncation analysis of peptide 38 |
SPOT |
[52] |
the variable region of the Vb 6.2 |
|
|
|
T-cell receptor |
|
|
|
mab 3E12 against Kx blood group |
overlapping peptides derived from |
SPOT |
[72] |
antigen and spectrin β-chain |
epitope regions in Kx blood group |
|
|
|
antigen and spectrin β-chain |
|
|
2 anti-tubulin-tyrosine ligase (TTL) |
peptide scan of pig TTL |
SPOT |
[135] |
mabs |
|
|
|
anti-cardiac troponin I mab 11E12 |
alanine walks of mab 11E12 binding |
SPOT |
[147] |
|
peptides |
|
|
10 sera from patients with malaria |
peptide scan of block 17 of merozoite |
SPOT |
[164] |
|
surface glycoprotein-1 (MSP1) of |
|
|
|
Plasmodium falciparum |
|
|
anti-p24 (HIV-1) mab CB4-1 |
libraries with all possible single step |
SPOT |
[212] |
|
transition pathways between 3 |
|
|
|
sequentially and structually |
|
|
|
unrelated mab CB4-1 binding |
|
|
|
peptides; substitutional analyses of |
|
|
|
peptides from selected transition |
|
|
|
pathways |
|
|
35S-labeled calmodulin |
mastpoparan |
SPOT |
[223] |
|
(Ac-INLKALAALAKKIL) and |
|
|
truncation and deletion analogs
(cont.)
238 ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI
TABLE 7.4. Continued
Screening Molecule Library Technology Reference
pIII phage display library of calmodulin variants
pIII phage display scFv library presenting the antibody repertoire of a mouse immunized with the recombinant extracellular domain of the C3a receptor
anti-amyloid β (Aβ) mouse mabs WO-2, G2-10, and G2-11
mouse and rabbit antisera against capsid proteins VP0, VP3, and VP1 of human parechovirus 1 (HPEV 1)
anti-porcine circovirus (PCV) sera from pigs
sera and affinity purified antibodies from patients with systemic sclerosis
8 sera from anti-centromere autoantibody positive patients
sera from coeliac disease patients containing anti-gliadin antibodies
polyclonal mouse antibodies against a protective epitope from measles virus fusion protein
14 mabs against human or Xenopus
p53
11 sera from Mycoplasma bovis infected cows with symptoms of mastitis or pneumonia; 3 anti-variable surface lipoproteins (Vsps) mabs
anti-p193 (from major vault protein, MVP) mabs p193-4, p193-6, and p193-10
pool of 10 sera from papilloma bearing hamsters; pool of 19 sera from hamster polyomavirus (HaPV)-infected papilloma-free hamsters; rabbit sera against against intact SV40 virions and JCV-VP1 virus like particles
mab 26/9 against peptide HA175-110 of hemagglutinin of influenza (X47:HA1)
mastpoparan (Ac-INLKALAALAKKIL) and truncation and deletion analogs
partial peptide scan of the extracellular domain of the C3a receptor
peptide scans of residues 1-42 of |
SPOT |
[238] |
amyloid β (Aβ) |
|
|
peptide scans of the capsid proteins |
SPOT |
[243] |
VP0, VP3, and VP1 of HPEV 1 |
|
|
partial peptide scans of ORF-1 and |
SPOT |
[339] |
complete peptide scans of ORF-2 |
|
|
and ORF-3 from PCV1 and PCV2 |
|
|
peptide scans of centromeric protein A |
SPOT |
[340] |
(CENP-A); length analyses of |
|
|
selected antigenic regions |
|
|
partial peptide scans of the centromere |
SPOT |
[378] |
protein CENP-A |
|
|
peptide scans of α/β- and γ -gliadin; |
SPOT |
[390] |
substitution analogs of a selected |
|
|
peptide |
|
|
peptide scan of the peptide used for |
SPOT |
[396] |
immunization |
|
|
peptide scans of the N-terminal part of |
SPOT |
[426] |
p53; truncation analyses and alanine |
|
|
walks of selected peptides |
|
|
peptides scans of Vsp; peptide |
SPOT |
[485] |
truncation analyses of the Vsp |
|
|
repetitive regions |
|
|
partial peptide scan of amino acids |
MPC |
[498] |
408–611 of the p193 protein |
|
|
peptide scan of the hamster |
SPOT |
[515] |
polyomavirus (HaPV) major capsid |
|
|
protein VP1 |
|
|
4450 randomly generated cyclic 12-mer |
MPC |
[518] |
peptides (XXCXXXXXXCXX), |
|
|
4450 randomly generated linear |
|
|
12-mer peptides and substitutional analyses of selected hits from the random libraries
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
239 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
phosphorylation specific anti-human |
peptide scan of phosphorylated and |
SPOT |
[551] |
tau protein mab AD2 |
unphosphorylated tau protein and |
|
|
|
alanine walks of selected peptides |
|
|
anti-glycoprotein G-1 (gG-1) |
peptide scans of gG-1 (HSV-1) |
SPOT |
[554] |
antibodies purified from herpes |
|
|
|
simplex virus 1 (HSV-1) patients |
|
|
|
anti-p24 (HIV-1) scFv CB4-1 and 2 |
substitutional analyses of the |
SPOT |
[595] |
mutants thereof |
p24-derived wt epitope and a |
|
|
|
mimotope |
|
|
mouse sera against peptides from Der |
alanine walks of peptides derived from |
SPOT |
[599] |
p2 (house dust mite |
Der p2 |
|
|
Dermatophogoides pteronyssinus) |
|
|
|
anti-plastidic phosphorylase (Pho 1a) |
peptide scan of Pho 1a; complete |
SPOT |
[9] |
from Solanum tuberosum L. mab |
substitutional analysis of the Pho |
|
|
|
1a-derived epitope peptide |
|
|
anti-α-bungarotoxin scFv C12; |
peptide scan of α-bungarotoxin |
SPOT |
[58] |
nicotinic acetylcholine receptor |
|
|
|
nAchR |
|
|
|
sera from cow’s milk allergy patients |
peptide scans of αs1-casein |
SPOT |
[77] |
(IgG and IgE antibody detection) |
|
|
|
polyclonal sera from mice, rabbits and |
peptide scans of TsNTxP and alanine |
SPOT |
[78] |
horses against a non-toxic protein |
substitution scans of selected |
|
|
from the venom of the noxious |
peptides; peptide scans of active |
|
|
scorpion Tityus serrulatus (TsNTxP) |
toxins from the venom of Tityus |
|
|
|
serrulatus |
|
|
anti-tobacco mosaic virus protein |
partial peptide scan of tobacco mosaic |
SPOT |
[86] |
(TMVP) Fab 57P |
virus protein (TMVP); substitutional |
|
|
|
analysis, truncation analysis and |
|
|
|
alanine walk of a selected peptide |
|
|
anti-vascular endothelial cadherin |
peptide scans of the extracellular |
SPOT |
[93] |
(VE-cadherin) mabs BV6 and Cad 5 |
domain of vascular endothelial |
|
|
p60c-src protein tyrosine kinase and |
cadherin (VE-cadherin) |
|
|
Ttds-EEIYGEFF |
DIPP |
[143] |
|
γ 32P-ATP |
|
|
|
strepavidin-Cy3 conjugate; avidin-Cy5 |
biotin, HPYPP and WSHPQFEK |
|
|
conjugate |
|
|
|
anti-human insulin mab HB125 and |
biotin, wGeyidvk, pqrGstG, |
|
|
anti-mouse IgG-Cy5 conjugate |
WSHPQFEK and YGGFL |
|
|
WEHI-231 cells and negative control |
wGeyidvk |
|
|
cells |
|
|
|
anti-genome-derived Ag 33 (GNA33) |
peptide scans of genome-derived Ag |
SPOT |
[182] |
mab 25; anti-loop 4 of porin A mab |
33 (GNA33) of Neisseria |
|
|
P1.2 |
meningitidis and loop 4 of porin A |
|
|
anti-transforming growth factor α |
5 substitutional analyses of linear and |
SPOT |
[191] |
(TGFα) mab Tab2 |
cyclic (disulfide cyclization and |
|
|
|
amide cyclization from the N-α to |
|
|
|
the C-terminal glutamic acid side |
|
|
|
chain) analogs of the epitope |
|
|
scFv-phage library; anti-C3a receptor |
peptide scans of the 2e loop of C3a |
SPOT |
[199] |
2e loop scFvs E10 and E6 |
receptor |
|
|
(cont.)
240
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
sera from children with cow’s milk |
peptide scans of α-lactalbumin and |
SPOT |
[235] |
allergy |
β-lactalbumin |
|
|
anti-Ha-ras antibody mAb-10 |
peptide scan of the Ha-ras protein |
SPOT |
[294] |
sera from patients with systemic |
complete substitutional analyses of the |
SPOT |
[341] |
sclerosis, rheumatoid arthritis and |
centromere-associated protein A |
|
|
undefined connective tissue disease; |
(CENP-A) epitope GPRRR; |
|
|
control sera |
combinatorial library of the type |
|
|
|
GPB1RB2; libraries of mimotopes |
|
|
|
and homologous epitopes from |
|
|
|
potential autoantigens |
|
|
mab R5 recognizing prolamins from |
peptide scans from α- and γ -type |
SPOT |
[391] |
wheat (glidins), barley (hordeins) |
gliadin |
|
|
and rye (secalins) |
|
|
|
sera from Trypanosoma cruzi infected |
peptide scan of trans-sialidase from |
SPOT |
[424] |
patients (Chagas’ disease) and sera |
Trypanosoma cruzi |
|
|
from experimentally infected mice |
|
|
|
and rabbits |
|
|
|
anti-transforming growth factor α |
peptoidic building block substitutional |
SPOT |
[456] |
(TGFα) mab Tab2 |
analyses of the mab Tab2 peptide |
|
|
|
epitope VVSHFND and of |
|
|
|
peptomers and peptoids derived |
|
|
|
thereof |
|
|
5 anti-CEA (carcinoembryonic |
peptide scan of CEA |
SPOT |
[520] |
antigen) mabs, rabbit and goat |
(carcinoembryonic antigen) |
|
|
anti-CEA sera |
|
|
|
monoclonal antibodies A, 32F81, B, |
randomly generated libraries of 3640 |
MPC |
[561] |
A6.6A |
or 4550 defined peptides |
|
|
10 sera from children who achieved |
6 selected peptides from αs1-casein |
SPOT |
[566] |
clinical tolerance against cow’s milk |
and β-casein |
|
|
allergens; 10 sera from patients with |
|
|
|
persistent cow’s milk allergy (CMA) |
|
|
|
anti-β-Gal 14-3-3 fusion protein |
peptide scan of Chlamydomonas |
SPOT |
[570] |
polyclonal antibody |
reinhardtii 14-3-3- protein |
|
|
anti-phosphotyrosine mabs 4G10, |
peptides containing phosphor-Tyr or |
DIPP |
[571] |
PY20, pTyr100; anti-acetyl-lysine |
acetyl-Lys |
|
|
polyclonal antibody |
|
|
|
2 rabbit sera against TsNTxP and TsIV |
peptide scans of TsNTxP and TsVI |
SPOT |
[11] |
that are two components of the |
from the venom of scorpion Tityus |
|
|
venom of scorpion Tityus serrulatus) |
serrulatus |
|
|
several sera as well as pooled sera from |
peptide scans of BDV-N and BDV-P |
SPOT |
[43] |
borna disease virus (BDV ) infected |
proteins; length analysis of a |
|
|
mice, rats, horses, and humans; 1 |
selected epitope |
|
|
anti-nucleoprotein (N) of BDV mab; |
|
|
|
1 anti-phosphoprotein (P) of BDV |
|
|
|
mab |
|
|
|
Practical protocols describing the prediction of structural features of peptides |
SPOT |
[49] |
|
using amino acid substitution scans, complete substitutional analyses and |
|
|
|
double mutation (“dipeptide libraries”) exemplified by the PM/Scl-100 epitope |
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
241 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
Practical protocols to optimize the mapping of antibody epitopes and |
SPOT |
[59] |
|
protein-protein interactions with respect to protein concentrations, blocking |
|
|
|
conditions, detection systems, and the efficiency of the regeneration procedures |
|
|
|
sera from 13 cow’s milk allergic |
peptide scan of αs2-casein |
SPOT |
[69] |
children |
|
|
|
anti-E6 oncoprotein (papillomvirus |
partial E6 peptide scan; truncation |
SPOT |
[87] |
type 16) mabs 1F1, 6F4, and scFv |
analyses, alanine substitution scans, |
|
|
1F4 |
and complete L- amino acid |
|
|
|
substitutional analses of selected |
|
|
|
peptides |
|
|
mixture of anti-phosphotyrosine |
phosphotyrosine-containing peptides |
SPOT |
[140] |
antibodies, POD-conjugated |
derived from human insulin |
|
|
anti-mouse antibody |
receptor; degenerate SPOT library of |
|
|
|
general structure AABX1ZX2BAA |
|
|
|
(Z = phosphotyrosine, B = mixture |
|
|
|
of 20 natural amino acids, X defined |
|
|
|
amino acids) and peptides derived |
|
|
|
from human STAT 5A containing |
|
|
|
both phosphotyrosine and |
|
|
|
phosphothreonine residues |
|
|
sera from older patients with persistent |
25 peptides representing epitopes on |
SPOT |
[236] |
cow’s milk allergy; sera from |
cow’s milk proteins: 5 epitopes on |
|
|
younger children with decreasing |
αs1-casein, 5 on αs2-casein, 9 on |
|
|
milk-specific IgE antibodies |
κ-casein, 1 on α-lactalbumin, and 5 |
|
|
|
on β-lactoglobulin) |
|
|
Practical protocols for mapping monoclonal and polyclonal antibody epitopes |
SPOT |
[261] |
|
using peptide scans, length analyses, amino acid substitution scans and |
|
|
|
complete substitutional analyses |
|
|
|
anti-p53 mAb DO-1 |
peptides SDLHKL, DSLGKL, and |
LDPS |
[265] |
fluorescence shift following Pb2+ or |
SGLHKL |
|
|
As3+ binding |
dns (dansyl)-ECEE, dns-CCCC, |
|
|
|
dns-GGGG, EEEE |
|
|
5 murine mabs against glycoprotein |
peptide scans of gG-2 of HSV-2 |
SPOT |
[322] |
G-2 (gG-2) of herpes simplex virus |
|
|
|
type 2 (HSV-2) |
|
|
|
Practical protocols for (a) affinity purification of subfractions from polyclonal |
SPOT |
[342] |
|
sera that are specific for a defined linear epitope and (b) competition assays on |
|
|
|
peptide arrays |
|
|
|
12 sera from a patient with systemic |
peptide scans of centromeric protein A |
SPOT |
[343] |
sclerosis |
(CENP-A) as well as several |
|
|
|
mimotopes from potential |
|
|
|
autoantigens |
|
|
sera from HCV and EBV patients and |
peptides from HCV core and NS4 and |
DIPP |
[361] |
negative control sera |
EBV capsid, negative control |
|
|
|
peptide |
|
|
anti-SA-Le (tetrasaccharide) mab |
L-substitutional analysis of the NS19-9 |
SPOT |
[386] |
NS19-9 |
epitope DLWDWVVGKPAG |
|
|
anti-p53 antibody (PAb240) |
substitutional analysis of the PAb240 |
LDPS |
[406] |
|
peptide epitope including |
|
|
|
proteinogenic amino acids and |
|
|
|
unnatural building blocks; length |
|
|
|
analysis of the epitope |
|
|
(cont.)
242 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
anti-IL-10 mab CB/RS/13; |
5520-membered library of randomly |
SPOT |
[458] |
anti-transforming growth factor α |
generated 15-mer L-peptides; 8 |
|
|
(TGFα) mab Tab2; anti-p24 |
substitutional analyses of selected |
|
|
(HIV-1) mab CB4-1 |
antibody-binding peptides |
|
|
different pooled sera from autoimmune |
immunodominant peptides from |
DIPP |
[472] |
patients; 2 sera from single systemic |
snRNP proteins, Sm proteins, |
|
|
lupus erythematodes (SLE) patients; |
myelin basic protein (MBP), poly A |
|
|
negative control sera; |
ribose polymerase (PARP), and |
|
|
|
histones H1, H2A, H2B, H3, and H4 |
|
|
sera from mice immunized with |
selected peptides derived from myelin |
DIPP |
[475] |
myelin oligodendrocyte |
basis protein (MBP), proteolipid |
|
|
glycoprotein (MOG) p35–55, |
protein (PLP), myelin |
|
|
proteolipid protein (PLP) p139–151, |
oligodendrocyte glycoprotein |
|
|
and negative control serum |
(MOG), oligodendrocyte-specific |
|
|
|
protein (OSP), αb crystalline and |
|
|
|
other unspecified myelin proteins |
|
|
incubation with blood sera followed by |
peptide scan through major peanut |
DIPP |
[511] |
incubation with biotinylated |
allergens Ara h1, Ara h2 and Ara h3 |
|
|
anti-human IgE Ab and avidin-Cy3 |
(210 peptides) |
|
|
conjugate |
|
|
|
anti-FVIII mab ESH8 |
ESH8 binding peptides identified by |
SPOT |
[567] |
|
phage display; peptide scan of the |
|
|
|
C2 domain of blood coagulation |
|
|
|
factor VIII |
|
|
anti-FLAG mab M2 |
FLAG epitope; 3 single site alanine |
DIPP |
[581] |
|
substitutions of the FLAG epitope; |
|
|
|
HA epitope |
|
|
pooled sera from Parietaria judaica |
peptide scans of the Par j 1 and 2 |
SPOT |
[17] |
allergic patients |
allergens from Parietaria judaica |
|
|
|
pollen |
|
|
sera from peanut allergy patients and |
8 peptides representing the |
SPOT |
[39] |
nonatopic control sera (detection of |
immunodominant epitopes of the |
|
|
IgE antibodies) |
peanut allergens Ara h 1, Ara h 2, |
|
|
|
and Ara h 3 |
|
|
individual and pooled sea from cow’s |
truncation libraries and alanine |
SPOT |
[89] |
milk allergy (CMA) patients |
substitution scans of peptides from |
|
|
|
the αs1-casein allergen |
|
|
anti-CD30 mabs Ber-H2, Ki-2, Ki-4, |
peptide scans of the extracellular |
SPOT |
[114] |
R4-4 |
domain of CD30 and substitutional |
|
|
|
analyses of selected antibody |
|
|
|
binding peptides |
|
|
FITC-labeled anti-RHSVV pAb240 |
multiple substitutional analysis of |
LDPS |
[172] |
|
RHSVV epitop using 28 different |
|
|
|
amino acids (2304 peptides) |
|
|
individual and pooled sera form |
peptide scan of the peach allergen |
SPOT |
[173] |
patients with peach allergy |
Pru p 3 and alanine substituted |
|
|
|
analogs of selected peptides |
|
|
anti-transforming growth factor α |
randomly generated library of 8000 |
SPOT |
[202] |
(TGFα) mab Tab2 |
hexapeptoids and -peptomers |
|
|